These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31053293)

  • 1. Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis.
    Yunis A; Doros G; Luptak I; Connors LH; Sam F
    Am J Cardiol; 2019 Jul; 124(1):122-130. PubMed ID: 31053293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients.
    Bartolini S; Baldasseroni S; Fattirolli F; Silverii MV; Piccioli L; Perfetto F; Marchionni N; Di Mario C; Martone R; Taborchi G; Morini S; Vignini E; Cappelli F
    Intern Emerg Med; 2021 Apr; 16(3):653-660. PubMed ID: 32918156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
    Yamamura S; Izumiya Y; Ishida T; Onoue Y; Kimura Y; Hanatani S; Araki S; Fujisue K; Sueta D; Kanazawa H; Takashio S; Usuku H; Sugamura K; Sakamoto K; Yamamoto E; Yamamuro M; Yasuda H; Kojima S; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
    Heart Vessels; 2017 Jun; 32(6):708-713. PubMed ID: 27882404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The minute ventilation/carbon dioxide production slope is prognostically superior to the oxygen uptake efficiency slope.
    Arena R; Myers J; Hsu L; Peberdy MA; Pinkstaff S; Bensimhon D; Chase P; Vicenzi M; Guazzi M
    J Card Fail; 2007 Aug; 13(6):462-9. PubMed ID: 17675060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study.
    Aimo A; Vergaro G; Castiglione V; Fabiani I; Barison A; Gentile F; Ferrari Chen YF; Giorgetti A; Genovesi D; Buda G; Franzini M; Piepoli M; Moscardini S; Rapezzi C; Fontana M; Passino C; Emdin M
    Eur J Prev Cardiol; 2024 Aug; 31(11):1410-1417. PubMed ID: 38456769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise oscillatory breathing and increased ventilation to carbon dioxide production slope in heart failure: an unfavorable combination with high prognostic value.
    Guazzi M; Arena R; Ascione A; Piepoli M; Guazzi MD;
    Am Heart J; 2007 May; 153(5):859-67. PubMed ID: 17452165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary exercise testing predicts prognosis in amyloid cardiomyopathy: a systematic review and meta-analysis.
    Cantone A; Serenelli M; Sanguettoli F; Maio D; Fabbri G; Dal Passo B; Agostoni P; Grazzi G; Campo G; Rapezzi C
    ESC Heart Fail; 2023 Aug; 10(4):2740-2744. PubMed ID: 37264762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison.
    Arena R; Myers J; Aslam SS; Varughese EB; Peberdy MA
    Am Heart J; 2004 Feb; 147(2):354-60. PubMed ID: 14760336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure prognosis over time: how the prognostic role of oxygen consumption and ventilatory efficiency during exercise has changed in the last 20 years.
    Paolillo S; Veglia F; Salvioni E; Corrà U; Piepoli M; Lagioia R; Limongelli G; Sinagra G; Cattadori G; Scardovi AB; Metra M; Senni M; Bonomi A; Scrutinio D; Raimondo R; Emdin M; Magrì D; Parati G; Re F; Cicoira M; Minà C; Correale M; Frigerio M; Bussotti M; Battaia E; Guazzi M; Badagliacca R; Di Lenarda A; Maggioni A; Passino C; Sciomer S; Pacileo G; Mapelli M; Vignati C; Clemenza F; Binno S; Lombardi C; Filardi PP; Agostoni P;
    Eur J Heart Fail; 2019 Feb; 21(2):208-217. PubMed ID: 30632680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Contraction Fraction by M-Mode Echocardiography Is Superior to Ejection Fraction in Predicting Mortality in Transthyretin Amyloidosis.
    Rubin J; Steidley DE; Carlsson M; Ong ML; Maurer MS
    J Card Fail; 2018 Aug; 24(8):504-511. PubMed ID: 30010028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan.
    Yamada T; Takashio S; Arima Y; Nishi M; Morioka M; Hirakawa K; Hanatani S; Fujisue K; Yamanaga K; Kanazawa H; Sueta D; Araki S; Usuku H; Nakamura T; Suzuki S; Yamamoto E; Ueda M; Kaikita K; Tsujita K
    ESC Heart Fail; 2020 Oct; 7(5):2829-2837. PubMed ID: 32672425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis.
    Patel RK; Bandera F; Venneri L; Porcari A; Razvi Y; Ioannou A; Chacko L; Martinez-Naharro A; Rauf MU; Knight D; Brown J; Petrie A; Wechalekar A; Whelan C; Lachmann H; Muthurangu V; Guazzi M; Hawkins PN; Gillmore JD; Fontana M
    JAMA Cardiol; 2024 Apr; 9(4):367-376. PubMed ID: 38446436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic ability of VE/VCO2 slope calculations using different exercise test time intervals in subjects with heart failure.
    Arena R; Humphrey R; Peberdy MA
    Eur J Cardiovasc Prev Rehabil; 2003 Dec; 10(6):463-8. PubMed ID: 14671470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Proteomic Profiling in Inherited (ATTRm) and Acquired (ATTRwt) Forms of Transthyretin-Associated Cardiac Amyloidosis.
    Chan GG; Koch CM; Connors LH
    J Proteome Res; 2017 Apr; 16(4):1659-1668. PubMed ID: 28196416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis.
    Annabi MS; Carter-Storch R; Zaroui A; Galat A; Oghina S; Kharoubi M; Bezard M; Derumeaux G; Fanen P; Lemonnier F; Poullot E; Itti E; Gallet R; Teiger E; Pibarot P; Damy T; Clavel MA
    J Am Heart Assoc; 2024 Jul; 13(13):e034723. PubMed ID: 38904242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
    Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
    Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
    González-López E; Gallego-Delgado M; Guzzo-Merello G; de Haro-Del Moral FJ; Cobo-Marcos M; Robles C; Bornstein B; Salas C; Lara-Pezzi E; Alonso-Pulpon L; Garcia-Pavia P
    Eur Heart J; 2015 Oct; 36(38):2585-94. PubMed ID: 26224076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.
    Vainshelboim B; Oliveira J; Fox BD; Kramer MR
    Respir Care; 2016 Aug; 61(8):1100-9. PubMed ID: 27165419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.
    Scheel PJ; Florido R; Hsu S; Murray B; Tichnell C; James CA; Agafonova J; Tandri H; Judge DP; Russell SD; Tedford RJ; Calkins H; Gilotra NA
    J Am Heart Assoc; 2020 Feb; 9(3):e013695. PubMed ID: 32009524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt).
    Sikora JL; Logue MW; Chan GG; Spencer BH; Prokaeva TB; Baldwin CT; Seldin DC; Connors LH
    Hum Genet; 2015 Jan; 134(1):111-21. PubMed ID: 25367359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.